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SUMMARY   
The purpose of creating the DIABNOR register is to study the quality of diabetes care in Norway. We will 
study  the  prevalence  of  serious  complications  ("hard  endpoints")  and  what  kind  of  treatment  patients 
receive and how these vary with age, gender, ethnicity, education and place of residence. It is a cross-
sectional study based on data from all hospital contacts in Norway between 2004 and 2010, linked to the 
National Prescription Database (NorPD) containing information on all drug treatment patients receive, not 
only  from  hospitals  but  also  from  general  practitioners.  Data  are  also  linked  to  Statistics  Norway  for 
collecting information about ethnicity, social status and marital status. Development of quality indicators 
(QI)  for  diabetes  is  also  an  objective  of  the  project,  including  indicators  to  measure  compliance  with 
guidelines and achievement of treatment goals. The researchers behind the project believe it is important to 
measure quality and differences in health care in order to improve the prognosis in this patient group. 
 
 
BACKGROUND 
 
There are reasons to believe that the quality of diabetes 
care  in  Norway  is  generally  good  and  equivalent  to 
other  European  countries,  based  on  rough  measures 
and some studies indicating that outcome measured as 
hard endpoints is improving (1-3). A few studies are 
showing that achievement of treatment goals in general 
practice is low (4,5), and there is a gap between guide-
lines and practice in the treatment of type 2 diabetes 
(6), but there are no broad national surveys or quality 
registers as basis for a general perception about quality 
in  care.  Some  particularly  important  questions  are 
whether the quality of treatment and the results vary 
with gender, ethnicity, social status and where you live 
in the country. 
  The DIABNOR project is a collaboration between 
the Norwegian Knowledge Centre for the Health Ser-
vices (NOKC), Women and Children’s division, Oslo 
University Hospital (OUS) and Institute of Health and 
Society, University of Oslo (UiO). The project aims to 
collect a large dataset from all Norwegian hospitals, 
obtained with a routine data collection client (the FS 
system)  (7),  and  link  the  data  to  the  databases  of 
Statistics  Norway,  to  the  central  population  register 
and to the National Prescription Database (NorPD). In 
addition  to  research  on  quality  aspects  of  diabetes 
treatment and care, there is a need for developing and 
publishing quality  indicators  for health services  pro-
vided to people with diabetes. The Nordic Council has 
initiated work in this area leading to a report giving 
recommendations  for  several  groups  of  diseases  in-
cluding diabetes (8). Internationally proposed diabetes 
quality indicators are showed in Table 1. 
 
 
OBJECTIVES 
 
The aims of DIABNOR are to study the prevalence of 
complications and mortality of diabetes in Norway and 
drug therapy in a nationwide hospital material for the 
period  2004-2010  and  if  the  quality  of  treatment  as 
measured on these parameters vary with age, gender, 
ethnicity, social status and residency. The structure is 
shown in Figure 1.   
1. To study the prevalence of diabetes complications, 
morbidity and death 
a. prevalence of diabetes complications, morbidity 
and death by age, gender, ethnicity, education 
and place of residence 
b. causes of death and variety of these in relation to 
age, gender, ethnicity, education and health 
region. 
c. time trends in complications and mortality and 
changes in the distribution of causes of death 
2. To study the social and geographical variation in 
the use of specialist health care 
a. use of specialized health care / medical services 
in relation to age, gender, ethnicity, education 
and place of residence 
b. pharmacological treatment of diabetes mellitus 
and variations in the use of different treatment 
combinations in relation to age, gender, ethnicity, 
education and place of residence 
3. To test the appropriateness of the data set (validity/ 
reliability) to develop evidence-based quality 
indicators in the diabetes area (established or new, 
single or compound) 
 
MATERIAL AND METHODS 
 
The study is based on medical and administrative data 
from all hospital admissions in Norway between 2004 
and  2010  (outpatient  clinics,  day  care  and  wards), 
about 1.3 million contacts with patients with diabetes 
mellitus as primary or secondary diagnosis or diabetes- 
related  diagnoses  and  procedures  (such  as  diabetic 
nephropathy + ESRD + dialysis). Complications are36    G. JONER 
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Figure 1.  Overview of the DIABNOR research project. 
 
 
 
Table 1.  Proposed Quality indicators (QI’s) in diabetes. 
 
 
Norwegian 
Medical 
Association 
Nordic 
Council of 
Ministers  OECD  WHO  Denmark  Sweden 
HbA1c within goal (%)  X  X  X      X 
Blood pressure within goal (%)            X 
Insulin shock (%)  X           
Readmission (unplanned hospitalization)    X    X     
Amputation, lower extremity (rate)    X  X       
Proportion of diabetes patients treated with 
   – antihypertensive 
   – ACE inhibitors 
   – angiotensin-II-ant. 
   – lipid lowering drugs 
           
X 
X 
X 
X 
 
 
 
measured  as  "hard  endpoints"  as  dialysis  treatment, 
laser treatment of eyes, acute heart disease (AMI) and 
stroke in patients with a diabetes diagnosis. When cal-
culating the prevalence of complications, only condi-
tions exclusively treated in hospitals are included. The 
number  of people with  diabetes  per  health region is 
unknown, but we assume that the proportion of per-
sons with diabetes mellitus are the same in all health 
regions,  based  on user rates of antidiabetic  drugs  in 
NorPD. We will also study the variation in time and 
time trend of mortality and causes of death based on 
the Central Population Register (register status: alive 
and living in Norway, emigrated or deceased) + Cause 
of Death Register (causes of death). The project will 
investigate whether the chosen therapy and prognosis 
varies among hospitals and about ethnicity, education 
and place of residence are associated with choice of 
treatment. Hospitals datasets will be linked to census 
data (gender, register status, address), Statistics Nor-
way  (ethnicity, education + income)  and  the  NorPD 
(all prescriptions 2004-2010 from any doctor). Deve-
lopment of quality indicators (QI’s) for diabetes will 
be started with validation of the internationally estab-
lished QI’s for Norwegian datasets. In addition, we use 
the  dataset  to  examine  the  possibility  of  developing 
new CI for diabetes, single or composite. This is im-
portant to ensure that ability to measure differences in 
the quality of treatment including the use of guidelines 
in health care may improve the prognosis for patients. 
  Based on data from NPR 2006  (9)  we have esti-
mated the number of hospital contacts for diabetes to 
approx.  170 000  a  year.  The  NPR  2006-dataset  was 
anonymized, so we do not know the number of indi-
viduals, but if the mean number of visits is two, the 
number represents 85 000 patients which is 45-55% of 
known subjects with diabetes in Norway (10). 
 
 
RESULTS 
 
As of April 2013, all hospitals in Norway (about 65) 
have provided research data to the knowledge centre 
and the dataset has been linked to the databases in SSB DIABNOR – A REGISTER STUDY OF MEDICAL QUALITY IN HEALTH CARE  37 
including  the  cause  of  Death  Register  and  NorPD. 
NOKC has several datasets from other projects (30-
days mortality) and test sets from the National Patient 
Register. Quality assurance tests based on comparing 
the  actual  data  set  to  the  “test  sets”  show  that  data 
quality is good and there is only one hospital that lacks 
complete outpatient data for the last 2 years. 
 
DISCUSSION   
The project is unique because it brings together com-
plete  clinical  data  for  nearly  all  treatment  of  people 
with diabetes in Norway and therefore allows research 
on quality of care and the use of treatment guidelines. 
The project can also display the geographical and so-
cial disparities in treatment and prognosis. The mate-
rial is subjects with diabetes with one or more hospital 
contacts in the 7-year period 2004-2010 and subjects 
only treated in primary care will not included. The lack 
of data from primary care is partly compensated by the 
fact that all the prescriptions from GPs to the patient in 
the material are included. 
  In  Norway  we  have  two  other  quality  registers: 
Norwegian Childhood Diabetes Register (NCDR) and 
the Norwegian Diabetes Register for adults. These re-
gisters collect data prospectively on newly registered 
patients,  while  DIABNOR  is  a  cross-sectional  study 
describing  the  status  today.  NCDR  publish  several 
good process indicators, but few result indicators, and 
the register for adults will be able to publish QIs in the 
future. The registers are complementary to each other 
and  will  be  able  to  make  comparisons  that  indicate 
whether  treatment  outcomes  are  improving  or  not. 
DIABNOR-register data is anonymized for researchers 
and cannot be linked to other registers. 
  An equivalent dataset has never been available to 
evaluate the care of diabetes in Norway. This unique 
research project will provide new and important results 
about the status of the Norwegian diabetes care and 
provide answers to research questions about the prog-
nosis of diabetes patients and the variation of treatment 
by age, gender, ethnicity, education and region. If the 
hypothesis  about  variation  in  prognosis  and  care  is 
confirmed,  measures  may  be  taken  to  improve  the 
treatment and care by identifying the weak leaks. The 
study may contribute to the improvement in the care of 
a widespread, severe and chronic disease. 
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